Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036690 (
sepsis
)
59,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In 1958-74 altogether 64 cases of bacteriologically verified infections of Listeria monocytogenes were diagnosed in Sweden in children, aged more than 27 days, and in adults. Immunosuppression predisposed to the disease. Thus, many patients had co-existing disorders, such as leukemia and alcoholism. Sixteen patients had been treated with corticosteroids, which were combined with cytostatic drugs in nine. Meningoencephalitis was diagnosed in 52 patients and was fatal in 16. The clinical symptoms did not differ from those in purulent meningitis caused by other bacteria. In the cerebrospinal fluid the cellular response was dominated by polymorphonuclear cells in 29 patients and by mononuclear cells in 20. Ten patients had
septicemia
, which was fatal in four. Clinical symptoms were dominated by
chills
, high fever and general prostration. One patient had pleurisy and one an abscess of the neck; both recovered. Serotypes 1 and 4b prevailed and were equally common. Many patients developed raised antibody titers in both the O-agglutination test and the complement fixation test. The titers were often not positive until after a month. Moderate granulocytosis was the rule and monocytosis was rarely seen. Ampicillin alone or combined with an aminoglycoside seemed to be the drug of choice in the treatment of listeriosis. An alternative drug was tetracycline. Most deaths occurred within six days of onset of the illness. Early diagnosis and treatment were imperative. Most patients recovered and serious sequelae were rare.
...
PMID:Clinical aspects on 64 cases of juvenile and adult listeriosis in Sweden. 10 52
A case study of
sepsis
of pregnancy associated with a shield-type intrauterine device (IUD) is reported. The patient presented with a 12-hour history of
chills
and fever, but no other complaints. A pregnancy of 14-16 weeks gestation, with the IUD in place, was confirmed. The fetus, placenta, and IUD were evacuated vaginally and curettage was performed. Histopathologic analysis revealed extensive bacterial colonization of the maternal side of the membranes. Microscopic sections of the placenta and fetal organs showed no remarkable characteristics. Possible explanations of the mechanism of severe maternal
sepsis
during pregnancy are briefly discussed.
...
PMID:Maternal midtrimester sepsis in association with the intrauterine contraceptive device: early histopathologic findings. 110 59
The diagnosis of urinary tract
sepsis
is being made more often today because of increased awareness of the condition and improved techniques in the detection and management of genitourinary disorders. Patients developing urinary tract
sepsis
(bacteremia or
septicemia
) usually demonstrate certain predisposing factors: underlying chronic disease, advanced age, general debility, or recent urinary tract
sepsis
is easily made in a patient who has a sudden onset of fever,
chills
, malaise, nausea, and vomiting, along with tachycardia and a drop in blood pressure. Cultures should be taken from urine and blood samples, but therapy should be instituted immediately rather than after obtaining the results of cultures.
...
PMID:Treatment of genitourinary infections. 122 Sep 5
Interleukin 2, has frequent and important side effects. Toxic effects observed are systemic (fever,
chills
, malaise), hemodynamic (capillary leak syndrome, hypotension), cardiac (arrhythmia, infarction), renal (renal dysfunction), infectious (
septicemia
), cutaneous, hematologic, gastrointestinal, endocrinologic and metabolic. Side effects are dose-dependent, generally reversible, with a mortality from 1 to 3%. Regimens of administration and other cytokine combinations affect interleukin 2 toxicity. If the treatment of these side effects is well known, selection of patients and specialized care unit remain always necessary.
...
PMID:[Adverse effects of interleukin 2]. 136 55
The case records of 69 patients who had pancreatic pseudocysts were reviewed retrospectively. All patients had abdominal pain and tenderness, 38 had nausea and vomiting, 9 had
chills
and fever and 5 had jaundice. Forty-eight patients had elevated body temperatures and 26 had elevated leukocyte counts. A history of alcoholism was obtained in 48 patients. Ultrasonography demonstrated 54 pseudocysts near the body of the pancreas, 8 near the tail and 7 near the head. Thirty-nine patients had internal drainage, 16 had laparotomy and external drainage and 14 had percutaneous catheter drainage. One of these 14 patients died of uncontrollable
sepsis
. Six of the 39 patients who had internal drainage had clinical evidence of
sepsis
(4 had septic complications postoperatively, and 2 died); the remaining 33 patients who had noninfected pseudocysts left hospital within 20 days of operation. However, only four of nine patients who had percutaneous drainage for noninfected pseudocysts left hospital within 20 days of the procedure. Thus, the authors recommend that infected pancreatic pseudocysts be managed by percutaneous catheter drainage and noninfected pseudocysts by internal drainage.
...
PMID:Pancreatic pseudocysts: the role of percutaneous catheter drainage. 149 40
In a 6-month period, 17 consecutive unselected patients undergoing emergency or elective endoscopic variceal band ligation were evaluated prospectively for clinical and bacteriological signs of bacteremia after each treatment session. None had signs of
sepsis
, fever, or
chills
; however, in one patient, a coagulase-negative Staphylococcus epidermidis was cultured from peripheral blood at 5 but not 30 min after the procedure. These data indicate that, in contrast to sclerotherapy, endoscopic variceal ligation rarely induces bacteremia.
...
PMID:Bacteremia after endoscopic band ligation of esophageal varices. 160 85
This study was designated to establish the incidence of septic complications associated with Nd:YAG-laser treatment of varied gastrointestinal lesions. A total of 30 laser procedures were performed for 27 patients with both upper and lower gastrointestinal diseases. Thirty minutes after the completion of laser therapy, blood culture was obtained from each patient. Only one patient developed
sepsis
with fever,
chills
and positive blood culture, the organism isolated was Streptococcus mitis. All the other patients tolerated the treatment well and without signs of septic complications. According to this study, antibiotic prophylaxis is not necessary for gastrointestinal laser treatment. However, the conclusions must be cautious due to the small number of patients included in this study.
...
PMID:Septic complications of endoscopic laser treatment of gastrointestinal diseases. 162 47
Marrow is cryopreserved for use in autologous bone marrow transplants, but little is known of the incidence of reactions in patients transfused with these cryopreserved marrows. Reactions in patients transfused during a 4-year period with 134 autologous marrows cryopreserved in dimethyl sulfoxide (DMSO) were compared with those in patients transfused with marrow that had been collected from HLA-compatible donors and that had not been cryopreserved. Patients transfused with cryopreserved marrow had significantly more nausea (44.8 vs. 14.1%; p less than 0.0005), vomiting (23.9 vs. 8.5%; p less than 0.01),
chills
(31.3 vs. 1.4%; p less than 0.0005), and fever (17.9 vs. 0%; p less than 0.005) than patients transfused with fresh allogeneic marrow. The incidence of emesis correlated with the dose of DMSO received, but that of nausea did not. All cryopreserved marrows were cultured for bacteria at the time of transfusion and 17 (12.7%) were found to be positive. Only 1 of the 17 patients transfused with culture-positive marrow developed
sepsis
during the transplant course with the same organism that was present in the transfused marrow. Although the reactions in donors transfused with cryopreserved marrow were readily treated, this study suggests that the incidence of some reactions might be decreased by reducing the dose of DMSO transfused. Bacterial contamination of transfused marrow was a worrisome complication, and efforts should be made to improve marrow collection and processing techniques to minimize that risk.
...
PMID:Adverse reactions in patients transfused with cryopreserved marrow. 185 47
Catheter
sepsis
rates related to total parenteral nutrition are variable and depend on several patient-specific factors. These factors include the presence of immunosuppression or critical illness, the use of multiple intravascular catheters, and bacterial translocation. Catheter-related
sepsis
may present in the patient as fever,
chills
, change in mental status, hypotension, and leukocytosis. In patients with suspected catheter-related infection whose peripheral blood cultures do not grow the same organism as a blood culture drawn from the catheter, a guidewire exchange of the catheter has been shown to be effective. This technique should be considered a surgical procedure. Complications that are associated with guidewire exchange of central venous catheters are catheter malposition, embolism of air or septic thrombi, and cardiac arrhythmias.
...
PMID:Catheter infection control in parenteral nutrition. 190 74
Prophylactic platelet transfusion can prevent spontaneous hemorrhage in thrombocytopenic cancer patients undergoing intensive treatment, but it is limited by the development of platelet alloimmunization. Exclusive use of leukocyte-depleted blood products delays or prevents the development of platelet alloimmunization and also decreases the frequency of
chill
and fever reactions and reduces the transmission of cytomegalovirus and possibly other viral infections. Management of disease refractory to platelet transfusion remains a difficult problem. Intravenous immune globulin reduces the incidence of infection and may modify the severity of gram-negative
sepsis
, decreases the incidence of acute graft-versus-host disease, and may benefit some patients with platelet refractoriness. All blood products given to severely immunocompromised patients, including those undergoing chemoradiotherapy and high-dose therapies, should be irradiated. In addition, designated donor transfusions from first-degree relatives (even when given to immunocompetent patients) should be irradiated.
...
PMID:Use of blood and blood products for supportive care in cancer treatment. 193 20
1
2
3
4
5
6
7
8
9
10
Next >>